Annual Working Capital
$18.14 M
-$8.82 M-32.71%
December 31, 2023
Summary
- As of February 23, 2025, APRE annual working capital is $18.14 million, with the most recent change of -$8.82 million (-32.71%) on December 31, 2023.
- During the last 3 years, APRE annual working capital has fallen by -$58.95 million (-76.47%).
- APRE annual working capital is now -85.37% below its all-time high of $123.98 million, reached on December 31, 2019.
Performance
APRE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$22.85 M
-$3.62 M-13.67%
September 30, 2024
Summary
- As of February 23, 2025, APRE quarterly working capital is $22.85 million, with the most recent change of -$3.62 million (-13.67%) on September 30, 2024.
- Over the past year, APRE quarterly working capital has stayed the same.
- APRE quarterly working capital is now -81.57% below its all-time high of $123.98 million, reached on December 31, 2019.
Performance
APRE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
APRE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.7% | 0.0% |
| 3 y3 years | -76.5% | 0.0% |
| 5 y5 years | -70.3% | 0.0% |
APRE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.2% | at low | -53.6% | +26.0% |
| 5 y | 5-year | -85.4% | at low | -81.6% | +26.0% |
| alltime | all time | -85.4% | +1062.7% | -81.6% | +26.0% |
Aprea Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.85 M(-13.7%) |
| Jun 2024 | - | $26.47 M(-12.1%) |
| Mar 2024 | - | $30.10 M(+66.0%) |
| Dec 2023 | $18.14 M(-32.7%) | $18.14 M(-15.5%) |
| Sep 2023 | - | $21.47 M(-13.0%) |
| Jun 2023 | - | $24.69 M(-11.2%) |
| Mar 2023 | - | $27.79 M(+3.1%) |
| Dec 2022 | $26.95 M(-45.3%) | $26.95 M(-8.6%) |
| Sep 2022 | - | $29.48 M(-10.1%) |
| Jun 2022 | - | $32.78 M(-24.3%) |
| Mar 2022 | - | $43.32 M(-12.1%) |
| Dec 2021 | $49.27 M | $49.27 M(-7.3%) |
| Sep 2021 | - | $53.14 M(-12.5%) |
| Jun 2021 | - | $60.70 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $68.87 M(-10.7%) |
| Dec 2020 | $77.09 M(-37.8%) | $77.09 M(-13.1%) |
| Sep 2020 | - | $88.72 M(-11.1%) |
| Jun 2020 | - | $99.82 M(-11.7%) |
| Mar 2020 | - | $113.06 M(-8.8%) |
| Dec 2019 | $123.98 M(+102.8%) | $123.98 M(+162.9%) |
| Sep 2019 | - | $47.16 M(-16.1%) |
| Jun 2019 | - | $56.22 M(-8.0%) |
| Dec 2018 | $61.13 M(+199.2%) | $61.13 M |
| Dec 2017 | $20.43 M(-1363.2%) | - |
| Jun 2008 | -$1.62 M(+52.2%) | - |
| Jun 2007 | -$1.06 M(-43.6%) | - |
| Jun 2006 | -$1.88 M(>+9900.0%) | - |
| Dec 2004 | -$3300.00 | - |
FAQ
- What is Aprea Therapeutics annual working capital?
- What is the all time high annual working capital for Aprea Therapeutics?
- What is Aprea Therapeutics annual working capital year-on-year change?
- What is Aprea Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly working capital year-on-year change?
What is Aprea Therapeutics annual working capital?
The current annual working capital of APRE is $18.14 M
What is the all time high annual working capital for Aprea Therapeutics?
Aprea Therapeutics all-time high annual working capital is $123.98 M
What is Aprea Therapeutics annual working capital year-on-year change?
Over the past year, APRE annual working capital has changed by -$8.82 M (-32.71%)
What is Aprea Therapeutics quarterly working capital?
The current quarterly working capital of APRE is $22.85 M
What is the all time high quarterly working capital for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly working capital is $123.98 M
What is Aprea Therapeutics quarterly working capital year-on-year change?
Over the past year, APRE quarterly working capital has changed by $0.00 (0.00%)